|
1
|
Lloyd-Jones D, Adams RJ, Brown TM, et al:
Heart disease and stroke statistics - 2010 update: a report from
the American Heart Association. Circulation. 121:e46–e215. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
National Center for Cardiovascular
Diseases. Report on Cardiovascular Diseases in China 2007.
Encyclopedia of China Publishing House; Beijing: pp. 1002007
|
|
3
|
Anderson JL, Adams CD, Antman EM, et al:
ACC/AHA 2007 guidelines for the management of patients with
unstable angina/non-ST-Elevation myocardial infarction: a report of
the American College of Cardiology/American Heart Association Task
Force on Practice Guidelines (Writing Committee to Revise the 2002
Guidelines for the Management of Patients With Unstable
Angina/Non-ST-Elevation Myocardial Infarction) developed in
collaboration with the American College of Emergency Physicians,
the Society for Cardiovascular Angiography and Interventions, and
the Society of Thoracic Surgeons endorsed by the American
Association of Cardiovascular and Pulmonary Rehabilitation and the
Society for Academic Emergency Medicine. J Am Coll Cardiol.
50:e1–e157. 2007.
|
|
4
|
Davies MJ: The pathophysiology of acute
coronary syndromes. Heart. 83:361–366. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fichtlscherer S, Breuer S and Zeiher AM:
Prognostic value of systemic endothelial dysfunction in patients
with acute coronary syndromes: further evidence for the existence
of the ‘vulnerable’ patient. Circulation. 110:1926–1932.
2004.PubMed/NCBI
|
|
6
|
Libby P: Inflammation in atherosclerosis.
Nature. 420:868–874. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mizuno K, Satomura K, Miyamoto A, Arakawa
K, Shibuya T, Arai T, Kurita A, Nakamura H and Ambrose JA:
Angioscopic evaluation of coronary-artery thrombi in acute coronary
syndromes. N Engl J Med. 326:287–291. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Etienne-Manneville S and Hall A: Rho
GTPases in cell biology. Nature. 420:629–635. 2002. View Article : Google Scholar
|
|
9
|
Hart MJ, Jiang X, Kozasa T, Roscoe W,
Singer WD, Gilman AG, Sternweis PC and Bollag G: Direct stimulation
of the guanine nucleotide exchange activity of p115 RhoGEF by
Galpha13. Science. 280:2112–2114. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Amano M, Chihara K, Kimura K, Fukata Y,
Nakamura N, Matsuura Y and Kaibuchi K: Formation of actin stress
fibers and focal adhesions enhanced by Rho-kinase. Science.
275:1308–1311. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hall A: Rho GTPases and the actin
cytoskeleton. Science. 279:509–514. 1998. View Article : Google Scholar
|
|
12
|
Uehata M, Ishizaki T, Satoh H, Ono T,
Kawahara T, Morishita T, Tamakawa H, Yamagami K, Inui J, Maekawa M
and Narumiya S: Calcium sensitization of smooth muscle mediated by
a Rho-associated protein kinase in hypertension. Nature.
389:990–994. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Miyata K, Shimokawa H, Kandabashi T, Higo
T, Morishige K, Eto Y, Egashira K, Kaibuchi K and Takeshita A:
Rho-kinase is involved in macrophage-mediated formation of coronary
vascular lesions in pigs in vivo. Arterioscler Thromb Vasc Biol.
20:2351–2358. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Masumoto A, Hirooka Y, Shimokawa H,
Hironaga K, Setoguchi S and Takeshita A: Possible involvement of
Rho-kinase in the pathogenesis of hypertension in humans.
Hypertension. 38:1307–1310. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sandu OA, Ragolia L and Begum N: Diabetes
in the Goto-Kakizaki rat is accompanied by impaired
insulin-mediated myosin-bound phosphatase activation and vascular
smooth muscle cell relaxation. Diabetes. 49:2178–2189. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu PY, Chen JH, Lin LJ and Liao JK:
Increased Rho kinase activity in a Taiwanese population with
metabolic syndrome. J Am Coll Cardiol. 49:1619–1624. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Feske SK, Sorond FA, Henderson GV, Seto M,
Hitomi A, Kawasaki K, Sasaki Y, Asano T and Liao JK: Increased
leukocyte ROCK activity in patients after acute ischemic stroke.
Brain Res. 1257:89–93. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rikitake Y and Liao JK: Rho-kinase
mediates hyperglycemia-induced plasminogen activator inhibitor-1
expression in vascular endothelial cells. Circulation.
111:3261–3268. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hidaka T, Hata T, Soga J, Fujii Y, Idei N,
Fujimura N, Kihara Y, Noma K, Liao JK and Higashi Y: Increased
leukocyte rho kinase (ROCK) activity and endothelial dysfunction in
cigarette smokers. Hypertens Res. 33:354–359. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kandabashi T, Shimokawa H, Miyata K,
Kunihiro I, Kawano Y, Fukata Y, Higo T, Egashira K, Takahashi S,
Kaibuchi K and Takeshita A: Inhibition of myosin phosphatase by
upregulated rho-kinase plays a key role for coronary artery spasm
in a porcine model with interleukin-1beta. Circulation.
101:1319–1323. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kandabashi T, Shimokawa H, Mukai Y, Matoba
T, Kunihiro I, Morikawa K, Ito M, Takahashi S, Kaibuchi K and
Takeshita A: Involvement of rho-kinase in agonists-induced
contractions of arteriosclerotic human arteries. Arterioscler
Thromb Vasc Biol. 22:243–248. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mallat Z, Gojova A, Sauzeau V, Brun V,
Silvestre JS, Esposito B, Merval R, Groux H, Loirand G and Tedgui
A: Rho-associated protein kinase contributes to early
atherosclerotic lesion formation in mice. Circ Res. 93:884–888.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nohria A, Grunert ME, Rikitake Y, Noma K,
Prsic A, Ganz P, Liao JK and Creager MA: Rho kinase inhibition
improves endothelial function in human subjects with coronary
artery disease. Circ Res. 99:1426–1432. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Masumoto A, Mohri M, Shimokawa H, Urakami
L, Usui M and Takeshita A: Suppression of coronary artery spasm by
the Rho-kinase inhibitor fasudil in patients with vasospastic
angina. Circulation. 105:1545–1547. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kishi T, Hirooka Y, Masumoto A, Ito K,
Kimura Y, Inokuchi K, Tagawa T, Shimokawa H, Takeshita A and
Sunagawa K: Rho-kinase inhibitor improves increased vascular
resistance and impaired vasodilation of the forearm in patients
with heart failure. Circulation. 111:2741–2747. 2005. View Article : Google Scholar
|
|
26
|
Xiao B, Li X, Yan J, Yu X, Yang G, Xiao X,
Voltz JW, Zeldin DC and Wang DW: Overexpression of cytochrome P450
epoxygenases prevents development of hypertension in spontaneously
hypertensive rats by enhancing atrial natriuretic peptide. J
Pharmacol Exp Ther. 334:784–794. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhou Q, Gensch C and Liao JK:
Rho-associated coiled-coil-forming kinases (ROCKs): potential
targets for the treatment of atherosclerosis and vascular disease.
Trends Pharmacol Sci. 32:167–173. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dong M, Yan BP and Yu CM: Current status
of rho-associated kinases (ROCKs) in coronary atherosclerosis and
vasospasm. Cardiovasc Hematol Agents Med Chem. 7:322–330. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Morishige K, Shimokawa H, Eto Y,
Kandabashi T, Miyata K, Matsumoto Y, Hoshijima M, Kaibuchi K and
Takeshita A: Adenovirus-mediated transfer of dominant-negative
rho-kinase induces a regression of coronary arteriosclerosis in
pigs in vivo. Arterioscler Thromb Vasc Biol. 21:548–554. 2001.
View Article : Google Scholar
|
|
30
|
Wolfrum S, Dendorfer A, Rikitake Y,
Stalker TJ, Gong Y, Scalia R, Dominiak P and Liao JK: Inhibition of
Rho-kinase leads to rapid activation of phosphatidylinositol
3-kinase/protein kinase Akt and cardiovascular protection.
Arterioscler Thromb Vasc Biol. 24:1842–1847. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lee KW and Lip GY: Acute coronary
syndromes: Virchow’s triad revisited. Blood Coagul Fibrinolysis.
14:605–625. 2003.
|
|
32
|
Noma K, Rikitake Y, Oyama N, et al: ROCK1
mediates leukocyte recruitment and neointima formation following
vascular injury. J Clin Invest. 118:1632–1644. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Loirand G and Pacaud P: The role of Rho
protein signaling in hypertension. Nat Rev Cardiol. 7:637–647.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Budzyn K, Marley PD and Sobey CG:
Targeting Rho and Rho-kinase in the treatment of cardiovascular
disease. Trends Pharmacol Sci. 27:97–104. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shimokawa H and Rashid M: Development of
Rho-kinase inhibitors for cardiovascular medicine. Trends Pharmacol
Sci. 28:296–302. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Shimokawa H, Hiramori K, Iinuma H, Hosoda
S, Kishida H, Osada H, Katagiri T, Yamauchi K, Yui Y, Minamino T,
Nakashima M and Kato K: Anti-anginal effect of fasudil, a
Rho-kinase inhibitor, in patients with stable effort angina: a
multicenter study. J Cardiovasc Pharmacol. 40:751–761. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shibuya M, Hirai S, Seto M, Satoh S and
Ohtomo E; Fasudil Ischemic Stroke Study Group. Effects of fasudil
in acute ischemic stroke: results of a prospective
placebo-controlled double-blind trial. J Neurol Sci. 238:31–39.
2005. View Article : Google Scholar : PubMed/NCBI
|
